These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17452982)

  • 1. Roles of BCCIP in chromosome stability and cytokinesis.
    Meng X; Fan J; Shen Z
    Oncogene; 2007 Sep; 26(43):6253-60. PubMed ID: 17452982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair.
    Lu H; Guo X; Meng X; Liu J; Allen C; Wray J; Nickoloff JA; Shen Z
    Mol Cell Biol; 2005 Mar; 25(5):1949-57. PubMed ID: 15713648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of spindle integrity and mitotic fidelity by BCCIP.
    Huhn SC; Liu J; Ye C; Lu H; Jiang X; Feng X; Ganesan S; White E; Shen Z
    Oncogene; 2017 Aug; 36(33):4750-4766. PubMed ID: 28394342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas.
    Liu J; Lu H; Ohgaki H; Merlo A; Shen Z
    BMC Cancer; 2009 Aug; 9():268. PubMed ID: 19653894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1.
    Meng X; Lu H; Shen Z
    Cell Cycle; 2004 Nov; 3(11):1457-62. PubMed ID: 15539944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of BCCIP deficiency in mammary tumorigenesis.
    Droz-Rosario R; Lu H; Liu J; Liu NA; Ganesan S; Xia B; Haffty BG; Shen Z
    Breast Cancer Res; 2017 Oct; 19(1):115. PubMed ID: 29047390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues.
    Liu X; Cao L; Ni J; Liu N; Zhao X; Wang Y; Zhu L; Wang L; Wang J; Yue Y; Cai Y; Jin J
    Int J Oncol; 2013 Dec; 43(6):1925-34. PubMed ID: 24101097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential roles of BCCIP in mouse embryonic development and structural stability of chromosomes.
    Lu H; Huang YY; Mehrotra S; Droz-Rosario R; Liu J; Bhaumik M; White E; Shen Z
    PLoS Genet; 2011 Sep; 7(9):e1002291. PubMed ID: 21966279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the BCCIP gene for breast cancer susceptibility in breast/ovarian cancer families.
    Bonache S; Gutierrez-Enriquez S; Tenés A; Masas M; Balmaña J; Diez O
    Gynecol Oncol; 2013 Nov; 131(2):460-3. PubMed ID: 23911796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of G1 to S cell cycle progression by BCCIP beta.
    Meng X; Liu J; Shen Z
    Cell Cycle; 2004 Mar; 3(3):343-8. PubMed ID: 14726710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
    Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
    BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.
    Liu J; Yuan Y; Huan J; Shen Z
    Oncogene; 2001 Jan; 20(3):336-45. PubMed ID: 11313963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells.
    Su J; Sui Y; Ding J; Li F; Shen S; Yang Y; Lu Z; Wang F; Cao L; Liu X; Jin J; Cai Y
    Protein Cell; 2016 Oct; 7(10):749-760. PubMed ID: 27535137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer.
    Lingle WL; Lukasiewicz K; Salisbury JL
    Adv Exp Med Biol; 2005; 570():393-421. PubMed ID: 18727509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCCIP binds to and activates its promoter in a YY1-dependent fashion in HCT116 cells.
    Sui Y; Li F; Wu T; Ding J; Lu Z; Wang L; Yang Y; Wang F; Zhao L; Zhu H; Wei T; Jin J; Cai Y
    FEBS J; 2018 Aug; 285(16):3026-3040. PubMed ID: 29932276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability.
    Trachana V; van Wely KH; Guerrero AA; Fütterer A; Martínez-A C
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2691-6. PubMed ID: 17299043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lats1 suppresses centrosome overduplication by modulating the stability of Cdc25B.
    Mukai S; Yabuta N; Yoshida K; Okamoto A; Miura D; Furuta Y; Abe T; Nojima H
    Sci Rep; 2015 Nov; 5():16173. PubMed ID: 26530630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of human BCCIP and implications for binding and modification of partner proteins.
    Choi WS; Liu B; Shen Z; Yang W
    Protein Sci; 2021 Mar; 30(3):693-699. PubMed ID: 33452718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities.
    Shih HJ; Chu KL; Wu MH; Wu PH; Chang WW; Chu JS; Wang LH; Takeuchi H; Ouchi T; Hsu HL
    Cell Cycle; 2012 Mar; 11(5):934-52. PubMed ID: 22336915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spindle assembly checkpoint and centrosome abnormalities in oral cancer.
    Thirthagiri E; Robinson CM; Huntley S; Davies M; Yap LF; Prime SS; Paterson IC
    Cancer Lett; 2007 Dec; 258(2):276-85. PubMed ID: 17959302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.